FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3013219934> ?p ?o ?g. }

• W3013219934 endingPage "2278" @default.
• W3013219934 startingPage "2265" @default.
• W3013219934 abstract "Previous studies have identified the important roles of a long noncoding RNA called FGD5 antisense RNA 1 (FGD5-AS1) in several types of human cancer. Nonetheless, to our knowledge, the expression and functions of FGD5-AS1 in esophageal squamous cell carcinoma (ESCC) have not been clarified. In this study, we aimed to determine the expression status of long noncoding RNA FGD5-AS1 in ESCC, determine its participation in ESCC progression, and uncover the underlying mechanisms.ESCC tissue samples and paired normal adjacent tissues were collected to quantify FGD5-AS1 expression by reverse-transcription quantitative PCR. The effects of FGD5-AS1 on ESCC cell proliferation, apoptosis, migration, and invasion in vitro as well as tumor growth in vivo were studied using a Cell Counting Kit-8 assay, flow cytometry, Transwell migration and invasion assays, and an in vivo tumor xenograft experiment.FGD5-AS1 was found to be aberrantly upregulated in both ESCC tumors and cell lines compared to the control groups. Increased FGD5-AS1 expression manifested a close association with tumor size, TNM stage, and lymph node metastasis in patients with ESCC. Overall survival of patients with ESCC was shorter in the FGD5-AS1 high-expression group than in the FGD5-AS1 low-expression group. An FGD5-AS1 knockdown markedly attenuated ESCC cell proliferation, migration, and invasion and promoted apoptosis in vitro as well as slowed tumor growth in vivo. Mechanism investigation revealed that FGD5-AS1 can increase SP1 expression by sponging microRNA-383 (miR-383), thus functioning as a competing endogenous RNA. An miR-383 knockdown and recovery of SP1 expression attenuated the inhibition of the malignant characteristics of ESCC cells by the FGD5-AS1 knockdown.Thus, FGD5-AS1 enhances the aggressive phenotype of ESCC cells in vitro and in vivo via the miR-383-SP1 axis, which may represent a novel target for ESCC therapy." @default.
• W3013219934 created "2020-04-03" @default.
• W3013219934 creator A5000837512 @default.
• W3013219934 creator A5025225343 @default.
• W3013219934 creator A5040339174 @default.
• W3013219934 creator A5058988650 @default.
• W3013219934 creator A5085900067 @default.
• W3013219934 date "2020-03-01" @default.
• W3013219934 modified "2023-10-18" @default.
• W3013219934 title "<p>Long Noncoding RNA <em>FGD5-AS1</em> Acts as a Competing Endogenous RNA on microRNA-383 to Enhance the Malignant Characteristics of Esophageal Squamous Cell Carcinoma by Increasing SP1 Expression</p>" @default.
• W3013219934 cites W1578827040 @default.
• W3013219934 cites W2028418967 @default.
• W3013219934 cites W2062865068 @default.
• W3013219934 cites W2093404711 @default.
• W3013219934 cites W2103946207 @default.
• W3013219934 cites W2107277218 @default.
• W3013219934 cites W2164986334 @default.
• W3013219934 cites W2170384423 @default.
• W3013219934 cites W2201671538 @default.
• W3013219934 cites W2259090596 @default.
• W3013219934 cites W2341291028 @default.
• W3013219934 cites W2564304225 @default.
• W3013219934 cites W2565831753 @default.
• W3013219934 cites W2591421310 @default.
• W3013219934 cites W2593015661 @default.
• W3013219934 cites W2594438399 @default.
• W3013219934 cites W2595251399 @default.
• W3013219934 cites W2756102075 @default.
• W3013219934 cites W2766424725 @default.
• W3013219934 cites W2795806863 @default.
• W3013219934 cites W2800620450 @default.
• W3013219934 cites W2883158371 @default.
• W3013219934 cites W2888997408 @default.
• W3013219934 cites W2901590794 @default.
• W3013219934 cites W2905210007 @default.
• W3013219934 cites W2914376850 @default.
• W3013219934 cites W2917837889 @default.
• W3013219934 cites W2953838828 @default.
• W3013219934 cites W2964192728 @default.
• W3013219934 cites W2965695059 @default.
• W3013219934 cites W2968165264 @default.
• W3013219934 cites W2969207522 @default.
• W3013219934 cites W2969951198 @default.
• W3013219934 cites W2972644588 @default.
• W3013219934 cites W2974599597 @default.
• W3013219934 cites W2975341512 @default.
• W3013219934 cites W2976666657 @default.
• W3013219934 cites W2977495010 @default.
• W3013219934 cites W2997880701 @default.
• W3013219934 cites W4210685329 @default.
• W3013219934 cites W4230731164 @default.
• W3013219934 cites W4235578555 @default.
• W3013219934 cites W1964184380 @default.
• W3013219934 cites W2999509795 @default.
• W3013219934 doi "https://doi.org/10.2147/cmar.s236576" @default.
• W3013219934 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7105361" @default.
• W3013219934 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32273764" @default.
• W3013219934 hasPublicationYear "2020" @default.
• W3013219934 type Work @default.
• W3013219934 sameAs 3013219934 @default.
• W3013219934 citedByCount "15" @default.
• W3013219934 countsByYear W30132199342021 @default.
• W3013219934 countsByYear W30132199342022 @default.
• W3013219934 crossrefType "journal-article" @default.
• W3013219934 hasAuthorship W3013219934A5000837512 @default.
• W3013219934 hasAuthorship W3013219934A5025225343 @default.
• W3013219934 hasAuthorship W3013219934A5040339174 @default.
• W3013219934 hasAuthorship W3013219934A5058988650 @default.
• W3013219934 hasAuthorship W3013219934A5085900067 @default.
• W3013219934 hasBestOaLocation W30132199341 @default.
• W3013219934 hasConcept C104317684 @default.
• W3013219934 hasConcept C145059251 @default.
• W3013219934 hasConcept C1491633281 @default.
• W3013219934 hasConcept C150903083 @default.
• W3013219934 hasConcept C153911025 @default.
• W3013219934 hasConcept C173396325 @default.
• W3013219934 hasConcept C202416437 @default.
• W3013219934 hasConcept C207001950 @default.
• W3013219934 hasConcept C502942594 @default.
• W3013219934 hasConcept C54355233 @default.
• W3013219934 hasConcept C553184892 @default.
• W3013219934 hasConcept C55493867 @default.
• W3013219934 hasConcept C60365752 @default.
• W3013219934 hasConcept C62112901 @default.
• W3013219934 hasConcept C62203573 @default.
• W3013219934 hasConcept C67705224 @default.
• W3013219934 hasConcept C81885089 @default.
• W3013219934 hasConcept C86803240 @default.
• W3013219934 hasConceptScore W3013219934C104317684 @default.
• W3013219934 hasConceptScore W3013219934C145059251 @default.
• W3013219934 hasConceptScore W3013219934C1491633281 @default.
• W3013219934 hasConceptScore W3013219934C150903083 @default.
• W3013219934 hasConceptScore W3013219934C153911025 @default.
• W3013219934 hasConceptScore W3013219934C173396325 @default.
• W3013219934 hasConceptScore W3013219934C202416437 @default.
• W3013219934 hasConceptScore W3013219934C207001950 @default.
• W3013219934 hasConceptScore W3013219934C502942594 @default.
• W3013219934 hasConceptScore W3013219934C54355233 @default.

• next